![]() |
市場調查報告書
商品編碼
1980258
草藥市場規模、佔有率、成長及全球產業分析:按類型和應用的洞察,2026-2034年預測Herbal Medicine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受消費者對天然療法的偏好增強以及傳統醫療體系全球一體化的推動,全球草藥市場持續保持強勁成長動力。2025年,全球草藥市場規模為2,512.4億美元,預計2026年將成長至2,711.4億美元,到2034年將達到5,159.2億美元,預測期內(2026-2034年)的年複合成長率(CAGR)為8.37%。
到2025年,歐洲以 44.29%的市場佔有率引領全球市場,這反映出消費者對植物性補充劑的高度接受度以及對草藥產品的監管支持。
市場概覽
草藥是指由植物的根、葉、樹皮、種子和萃取物製成的植物來源產品。它們廣泛應用於製藥、營養保健品、機能性食品和個人護理領域。人們對預防性醫療保健意識的提高、慢性病盛行率的上升以及對潔淨標示配方的需求,推動市場擴張。
在亞太地區,阿育吠陀、傳統中醫、中草藥和尤那尼等傳統醫療體系仍然是主要需求來源,而在北美和歐洲,營養保健品和增強免疫力的補充劑越來越受歡迎。
草本市場趨勢
草本營養補充品消費量增加
全球對草藥營養補充品的需求激增。世界衛生組織(WHO)的資料顯示,已開發國家約有10%至50%的人口使用某種形式的草藥。在中國、印度、日本、越南、南非和孟加拉等開發中國家,草藥產品通常是一種價格低廉且易於取得的首選治療方案。
消費者越來越依賴草藥產品來增強免疫力、治療咳嗽感冒、腸胃問題、關節疼痛和發炎性疾病。這種對植物來源保健品的持續偏好預計將創造強勁的長期成長機會。
市場動態
市場促進因素
開發中國家的高需求
在許多中低收入國家,傳統中醫是醫療保健的基礎。全球超過80%的人口以某種形式依賴傳統醫學。草藥通常以乾藥、粉末、膠囊、茶劑或外用製劑的形式使用。某些發展中地區監管壁壘的缺失進一步推動了該產業的快速擴張。
市場限制因素
化妝品業的嚴格監管準則
對化妝品中草本成分的監管,尤其是在歐洲,是一項挑戰。安全檢驗、可追溯性要求以及對某些植物化合物的限制,都增加了合規成本並延長了核准流程。歐盟限制或禁止使用超過1600種化妝品成分,其中包括某些植物來源的物質,這可能會限制某些細分市場的成長。
市場機會
對天然化妝品成分的需求日益成長
個人護理和美容行業擁有巨大的成長潛力。消費者越來越傾向選擇植物來源護膚、護髮產品和潔淨標示的化妝品。製造商正透過順應永續發展和健康理念,以草本成分取代合成化學物質,開闢新的擴張途徑。
依用途
到2025年,藥品和膳食補充劑領域將佔據最大的市場佔有率。這主要得益於市場對膳食補充劑、草本蛋白粉、免疫增強劑和抗衰老產品的強勁需求。
受植物來源化妝品和草本護膚品需求不斷成長的推動,個人護理和美容產品領域預計將以 9.16%的年複合成長率實現最高成長,預計到2026年將佔市場佔有率的24.53%。
依形式
粉狀產品佔據市場主導地位,2025年市場規模達到1,186億美元,佔總需求的47.2%。這主要得益於傳統的消費習慣和產品易於配製。該細分市場預計將以8.44%的年複合成長率成長。
預計到2026年,液體和凝膠細分市場將佔據 35.11%的市場佔有率,並以 8.86%的年複合成長率成長,這得益於快速吸收以及在糖漿和外用溶液中日益成長的使用。
依通路
零售藥局和藥局是推動市場發展的主要力量,2025年市場規模達到993億美元,佔全球銷售額的39.5%。非處方藥的普及和消費者的高度信任是該領域主導的關鍵因素。
同時,受數位醫療、宅配服務和跨境線上銷售的普及推動,電子藥局和線上平台經歷最快的成長。
歐洲
2025年,歐洲市場規模達到1,112.7億美元,佔全球市場的44.29%,預計年複合成長率為7.79%。德國將引領該地區,2026年市場規模將達211.6億美元,其次是英國,2026年市場規模將達160.2億美元。
北美洲
預計到2025年,北美市場規模將達到352億美元,佔全球市場佔有率的13.99%,年複合成長率(CAGR)為8.18%,在所有地區中最高。預計到2026年,美國市場規模將達到239.1億美元。
亞太地區
預計到2025年,亞太地區市場規模將達到844億美元,佔全球市場佔有率的33.6%,年複合成長率為9.36%。預計中國市場規模在2025年將達到195億美元,在2026年將達到211.6億美元,而印度市場規模在2026年將達到75.5億美元。
南美洲、中東和非洲
預計到2025年,南美洲的市場規模將達到125億美元,而中東和非洲的市場規模將達到79億美元。預計這兩個地區在預測期內都將保持穩定成長。
The global herbal medicine market continues to demonstrate strong growth momentum, driven by rising consumer preference for natural therapeutics and increasing global integration of traditional medicine systems. The global herbal medicine market size was valued at USD 251.24 billion in 2025 and is projected to grow to USD 271.14 billion in 2026, reaching USD 515.92 billion by 2034, registering a CAGR of 8.37% during the forecast period (2026-2034).
In 2025, Europe dominated the global market with a 44.29% share, reflecting strong consumer adoption of botanical supplements and regulatory support for herbal products.
Market Overview
Herbal medicines are plant-derived products formulated from roots, leaves, bark, seeds, and extracts. They are widely used across pharmaceuticals, nutraceuticals, functional foods, and personal care applications. Growing awareness of preventive healthcare, increasing chronic disease prevalence, and demand for clean-label formulations are supporting market expansion.
Traditional systems such as Ayurveda, Traditional Chinese Medicine (TCM), Kampo, and Unani remain central to demand in Asia Pacific, while North America and Europe are witnessing rising adoption through nutraceuticals and immunity-boosting supplements.
Herbal Medicine Market Trends
Heightened Consumption of Herbal Dietary Supplements
The demand for herbal dietary supplements has surged globally. According to the World Health Organization (WHO), approximately 10-50% of the population in developed countries uses herbal medicines in some form. In developing countries such as China, India, Japan, Vietnam, South Africa, and Bangladesh, herbal products often serve as affordable and accessible primary treatment options.
Consumers increasingly rely on herbal products for immunity enhancement, cough and cold treatment, gastrointestinal issues, joint pain, and inflammatory conditions. This sustained shift toward botanical supplements is expected to create strong long-term growth opportunities.
Market Dynamics
Market Drivers
High Demand from Developing Countries
In many low- and middle-income countries, herbal medicine forms the backbone of primary healthcare. Over 80% of the global population relies partly on traditional medicine. Herbs are commonly used in dried, powdered, capsule, tea, or topical forms. Minimal regulatory barriers in certain developing regions further support rapid industry expansion.
Market Restraints
Strict Regulatory Guidelines in Cosmetics
Regulatory scrutiny over herbal raw materials in cosmetics, particularly in Europe, poses challenges. Safety validation, traceability requirements, and restrictions on certain botanical compounds increase compliance costs and extend approval timelines. The European Union has restricted or prohibited more than 1,600 cosmetic ingredients, including certain plant-derived substances, which may limit growth in specific segments.
Market Opportunities
Rising Demand for Natural Cosmetic Ingredients
The personal care and beauty industry presents significant growth potential. Consumers increasingly demand botanical-based skincare, haircare, and clean-label cosmetics. Manufacturers are replacing synthetic chemicals with herbal alternatives to align with sustainability and wellness trends, unlocking new expansion avenues.
By Application
The pharmaceutical & nutraceutical segment held the largest market share in 2025, driven by strong demand for dietary supplements, herbal protein powders, immunity boosters, and anti-aging products.
The personal care & beauty products segment is projected to grow at the fastest CAGR of 9.16%, accounting for 24.53% market share in 2026, supported by rising demand for botanical cosmetics and herbal skincare formulations.
By Form
The powder segment dominated the market, valued at USD 118.6 billion in 2025, accounting for 47.2% of total demand, supported by traditional consumption practices and ease of formulation. The segment is projected to grow at a CAGR of 8.44%.
The liquid & gel segment accounted for 35.11% share in 2026 and is expected to grow at a CAGR of 8.86%, supported by faster absorption and increasing use in syrups and topical solutions.
By Distribution Channel
The retail pharmacies/drug stores segment led the market, valued at USD 99.3 billion in 2025, representing 39.5% of global sales. OTC availability and strong consumer trust drive segment dominance.
Meanwhile, e-pharmacies & online platforms are witnessing the fastest growth, fueled by digital health adoption, home delivery services, and cross-border online sales.
Europe
Europe accounted for USD 111.27 billion in 2025, representing 44.29% of the global market, and is projected to grow at a CAGR of 7.79%. Germany leads the region, valued at USD 21.16 billion in 2026, followed by the U.K. at USD 16.02 billion in 2026.
North America
North America was valued at USD 35.2 billion in 2025, accounting for 13.99% market share, and is projected to register the fastest regional CAGR of 8.18%. The U.S. accounted for USD 23.91 billion in 2026.
Asia Pacific
Asia Pacific was valued at USD 84.4 billion in 2025, representing 33.6% of global share, and is projected to grow at a CAGR of 9.36%. China was valued at USD 19.5 billion in 2025, reaching USD 21.16 billion in 2026, while India reached USD 7.55 billion in 2026.
South America & Middle East & Africa
South America was valued at USD 12.5 billion in 2025, while the Middle East & Africa accounted for USD 7.9 billion in 2025. Both regions are expected to witness steady growth during the forecast period.
Competitive Landscape
Key companies operating in the global herbal medicine market include:
Companies are focusing on product innovation, digital expansion, sustainable sourcing, and collaborations with regional distributors to strengthen market position.
Conclusion
The global herbal medicine market is set for sustained growth, expanding from USD 251.24 billion in 2025 to USD 271.14 billion in 2026, and projected to reach USD 515.92 billion by 2034, at a CAGR of 8.37%. Europe remains the leading region with a 44.29% share in 2025, while Asia Pacific is expected to witness the fastest expansion. Rising consumer inclination toward natural healthcare, increasing nutraceutical demand, expanding cosmetic applications, and growing regulatory recognition of traditional medicine systems are expected to drive long-term market growth globally.
Segmentation By Application
By Form
By Distribution Channel
By Region